Oral Propanolol for Surgically Inaccessible Cavernous Malformations
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the role of propranolol as an alternative treatment
for cavernous malformation in patients that may not be ideal candidates for surgery.